Authors: Budde, Petra; Schulte, Imke; Appel, Annette; Neitz, Susanne; Kellmann, Markus; Tammen, Harald; Hess, Rudiger; Rose, Horst

Source: Combinatorial Chemistry & High Throughput Screening, Volume 8, Number 8, December 2005 , pp. 775-781(7)

Publisher: Bentham Science Publishers

Abstract:

Type 2 diabetes mellitus (T2DM) is caused by the failure of the pancreatic beta-cell to secrete sufficient insulin to compensate a decreased response of peripheral tissues to insulin action. The pathological events causing beta-cell dysfunctions are only poorly understood and early markers that would predict islet function are missing. In contrast to immunoassays, unbiased proteomic technologies provide the opportunity to screen for novel marker protein and peptides of T2DM. An important subset of the proteome, peptides and peptide hormones secreted by the pancreas are deregulated in T2DM. The mass range of peptides and small proteins (1-20 kDa) is only sufficiently targeted by peptidomics, a combination of liquid chromatographic and mass spectrometric (MS) peptide analysis. Here, we describe the application of isotope label-free quantitative peptidomics to display and quantify relevant changes in the level of pancreatic peptides and peptide hormones in a preclinical model of T2DM, the Lep ob/Lep ob mouse. The amino acid sequence of statistical relevant top candidates was determined by MS/MS fragmentation or Edman degradation. The comparison of lean versus obese mice revealed increased levels of islet-specific peptides that can be divided into the following categories 1) the major islet peptide hormones insulin, amylin and glucagon; 2) proinsulin and C-peptide and 3) novel processing products of secretogranin, glucagon and amylin. Furthermore, we found increased levels of proteins and peptides implicated in zymogen granule maturation (syncollin) and nutritional digestion. In summary, our findings demonstrate that peptidomics is a valid approach to screen for novel peptide biomarkers.

Keywords: Peptidomics; proteomics; biomarker; diabetes; pancreas; profiling; obesity; insulin; amylin

Document Type: Review article

DOI: http://dx.doi.org/10.2174/138620705774962535

Affiliations: 1: Medical Research, BioVisioN AG, Feodor-Lynen-Str. 5, D-30625 Hannover, Germany.

Publication date: 2005-12-01

More about this publication?

• Combinatorial Chemistry & High Throughput Screening publishes full length original research articles and reviews describing various topics in combinatorial chemistry (e.g. small molecules, peptide, nucleic acid or phage display libraries) and/or high throughput screening (e.g. developmental, practical or theoretical). Ancillary subjects of key importance, such as robotics and informatics, will also be covered by the journal. In these respective subject areas, Combinatorial Chemistry & High Throughput Screening is intended to function as the most comprehensive and up-to-date medium available. The journal should be of value to individuals engaged in the process of drug discoveryand development, in the settings of industry, academia or government.

Related content

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Budde, Petra ;  Schulte, Imke ;  Appel, Annette ;  Neitz, Susanne ;  Kellmann, Markus ;  Tammen, Harald ;  Hess, Rudiger ;  Rose, Horst

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers